Expert articles, patient stories, and breakthroughs from HAIF — the AI-powered Heart Failure Predictor trusted by clinicians and patients worldwide.
Heart failure is a global health crisis, yet for millions in underserved regions, life-saving cardiac care remains out of reach. HAIF's HFP is rewriting this narrative — making advanced cardiac diagnostics affordable and accessible to everyone, regardless of location or income.
Read Full Article →Heart failure costs the US over $150 billion annually — 75–80% from preventable hospitalizations. Early detection with HAIF can fundamentally change these outcomes for individuals and healthcare systems alike.
Fatigue, mild breathlessness, reduced stamina — subtle signs millions dismiss as aging or burnout. HAIF's HFP detects these silent threats before they escalate into a life-threatening crisis.
In today's hyper-connected world, chronic stress is a silent driver of cardiac decline. Learn how to recognize the warning signs and stay ahead of risk before stress becomes a crisis.
An 80-year-old patient shares how a routine HAIF test uncovered a major arterial blockage his doctors had missed — and how timely intervention gave him his energy and independence back.
Using patented algorithms and ECG signals from wearables or clinical devices, HAIF HFP delivers over 99% accurate heart failure risk assessments — no needle prick, no invasive procedure.
Why early detection is the single most impactful lever in the fight against heart failure — and how HAIF is making it a reality for millions.
30-second ECG signal from any compatible wearable or clinical device
Patented AI algorithms process the heart signal data in real time
Accurate heart failure risk prediction delivered in under 3 minutes
Traditional diagnostics — echocardiograms, stress tests, angiograms — are expensive, invasive, and typically reserved for more severe presentations. By the time they're ordered, the disease has often already progressed significantly.
"The earlier we detect, the more we save — not just in dollars, but in lives."
Heart failure costs the United States over $150 billion annually, with 75–80% of that burden coming from hospitalizations that could largely be avoided through early detection. For individual patients, managing HF averages nearly $30,000 per year.
HAIF's HFP — at under $10 per test — makes early, accurate detection economically viable at scale, for hospitals, clinics, and individuals alike.
Heart failure does not discriminate by age or lifestyle. These three cases illustrate how HAIF's early detection has changed — and saved — lives.
Fatigue attributed to anemia for years. A HAIF test flagged major arterial blockage. Successful intervention restored his energy and independence.
Slowing down on evening walks, assumed to be aging. HAIF flagged high heart failure risk. Early medication and lifestyle changes had her walking again.
Shortness of breath written off as burnout. HAIF revealed significant risk. Early action prevented a career-ending — and life-threatening — event.